Drug Uses

Lamisil Tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes.

How Taken

Lamisil comes as a tablet to take orally. It is usually taken once a day for 6 weeks for fingernail fungus and once a day for 12 weeks for toenail fungus. Take Lamisil exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Your fungus may not be completely cured until a few months after you finish taking Lamisil. This is because it takes time for a healthy nail to grow in.

Warnings/Precautions

Do not take Lamisil without first talking to your doctor if you have ever had an allergic reaction to it, liver disease, kidney disease, problems with your immune system, or blood problems. You may not be able to take Lamisil, or you may require a dosage adjustment or special monitoring if you have any of the conditions listed above. Lamisil is in the FDA pregnancy category B. This means that it is not expected to harm an unborn baby. Do not take Lamisil without first talking to your doctor if you are pregnant. Lamisil passes into breast milk and may affect a nursing baby. Do not take this medication without first talking to your doctor if you are breast-feeding a baby.

Missed Dose

Take the missed dose as soon as you remember. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and take the next one as directed. Do not take a double dose of this medication.

Possible Side Effects

If you experience any of the following serious side effects, stop taking Lamisil and seek emergency medical attention: an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives); a rash; changes in vision; or blood problems (detected by blood tests). In rare cases, Lamisil has caused severe liver damage, sometimes resulting in liver transplant or death. Notify your doctor immediately if you develop nausea, vomiting, abdominal pain, unusual fatigue, loss of appetite, yellow skin or eyes, itching, dark urine, or clay colored stools. These symptoms may be early signs of liver damage. Other, less serious side effects may be more likely to occur. Continue to take Lamisil and talk to your doctor if you experience nausea, upset stomach, or heartburn; diarrhea or flatulence; headache; or taste disturbances or a loss of taste. Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

Storage

Store tablets below 25o C (77o F); in a tight container. Protect from light.

Overdose

Clinical experience regarding overdose with Lamisil Tablets is limited. The symptoms of overdose included nausea, vomiting, abdominal pain, dizziness, rash, frequent urination, and headache. Seek emergency medical attention.

More Information

Avoid alcohol or use it in moderation while taking Lamisil. Alcohol and Lamisil can both affect the liver. Lamisil Tablets are contraindicated if you have a hypersensitivity to Lamisil.

Disclaimer

This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information.

Other info about Lamisil-oral at Wikipedia.org and other resources:

Body and oral motor aspects in a group of children with phonological delay/disorder
OBJETIVO: Comparar o desenvolvimento motor e aspectos orofaciais em crianças com transtorno e atraso fonológico. MÉTODOS: Participaram da pesquisa 80 crianças de cinco a 11 anos de idade pertencentes à rede escolar regular de um município da Grande Porto Alegre com alterações fonológicas. Foi realizada uma entrevista com os pais através de um questionário semi-estruturado. Em seguida, foram avaliados o sistema estomatognático e a fala das crianças, e o diagnóstico de transtorno ou atraso fonológico foi confirmado para cada sujeito. Para a análise estatística, foram utilizados os testes de Fisher e o Qui-quadrado com nível de significância de 5% (p

Description of the feeding dynamics of institutionalized elderly women
CONCLUSION: Environmental, cognitive and behavioral factors related to feeding were significantly present among the subjects of the study, putting deglutition at risk. Other specific deglutition difficulties were also identified. Managing these difficulties is important, in order to avoid health complications for elderly women. (Source: Revista da Sociedade Brasileira de Fonoaudiologia)

Speech-language pathology profile of the Dendê community: perspectives for future actions
CONCLUSION: It was verified that most prevalent Speech-Language Pathology alterations were related to the presence of oral habits, followed by oral and written language aspects. Nevertheless, a low level of hearing and voice complaints were reported. A situational diagnosis helps redirecting the activities practiced in the community, aiming its population. This is achieved through educational initiatives of health prevention and promotion, which should lead to better, quicker and more efficient results. (Source: Revista da Sociedade Brasileira de Fonoaudiologia)

Dysphagia in patients with Chagas' disease and Zenker's diverticulum
Descrevemos dois pacientes, um do sexo feminino e outro do sexo masculino, ambos com 64 anos, que apresentavam a associação entre divertículo de Zenker e esofagopatia provocada por doença de Chagas. Um dos pacientes iniciou com disfagia esofágica há cinco anos, que depois se associou a disfagia orofaríngea há nove meses. O outro paciente tinha disfagia orofaríngea há oito meses. Ambos tinham antecedentes de doença de Chagas. Os dois pacientes tinham alterações do exame clínico da deglutição, ou seja, dificuldade de ingestão de líquidos e pastosos. A ingestão era lenta e havia resíduos em cavidade oral, sem tosse após a deglutição. O diagnóstico foi feito por exame sorológico e estudo radiológico de faringe e esôfago, complementados por exame endoscópico. Os resu...

Oral contraceptives and hormone replacement therapy may protect women against brain aneurysms, study finds
Results from a new study suggest that oral contraceptives and hormone replacement therapy may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. (Source: ScienceDaily Headlines)